Literature DB >> 25390979

Cytomegalovirus retinitis after treatment with intravitreal triamcinolone acetonide in an immunocompetent patient.

Jason Hsu1, Eric Chen, James F Vander.   

Abstract

PURPOSE: To describe a case of cytomegalovirus (CMV) retinitis following intravitreal triamcinolone acetonide (IVTA) in an immunocompetent patient.
METHODS: A 77-year-old man with a history of diabetes mellitus developed retinal whitening with a vasculitis 6 weeks after receiving IVTA in the left eye. A vitreous biopsy was performed.
RESULTS: Polymerase chain reaction was positive for CMV (419,000 copies/mL). A complete medical evaluation, including a negative test for human immunodeficiency virus, showed no systemic evidence of immunosuppression except for a highly elevated hemoglobin A1C level.
CONCLUSION: CMV retinitis may be a rare complication of IVTA, possibly due to local ocular immunosuppression from the steroid medication. Poorly controlled diabetes mellitus may have contributed to this development.

Entities:  

Year:  2007        PMID: 25390979     DOI: 10.1097/ICB.0b013e31802ea61c

Source DB:  PubMed          Journal:  Retin Cases Brief Rep        ISSN: 1935-1089


  3 in total

Review 1.  Viral retinitis following intraocular or periocular corticosteroid administration: a case series and comprehensive review of the literature.

Authors:  Ako Takakura; Howard H Tessler; Debra A Goldstein; Yan Guex-Crosier; Chi-Chao Chan; Diane M Brown; Jennifer E Thorne; Robert Wang; Emmett T Cunningham
Journal:  Ocul Immunol Inflamm       Date:  2014-03-21       Impact factor: 3.070

2.  Good syndrome and other causes of cytomegalovirus retinitis in HIV-negative patients-case report and comprehensive review of the literature.

Authors:  Kenneth M Downes; Dariusz Tarasewicz; Laurie J Weisberg; Emmett T Cunningham
Journal:  J Ophthalmic Inflamm Infect       Date:  2016-01-25

3.  Cytomegalovirus retinitis after treatment with topical difluprednate in an aphakic eye of an immunocompetent patient.

Authors:  Richard I Kaplan; Brian K Do; Ronald C Gentile; Sanjay R Kedhar
Journal:  Am J Ophthalmol Case Rep       Date:  2019-09-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.